Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Thursday, March 28, 2024 · 699,447,459 Articles · 3+ Million Readers

Analysis: Positioning to Benefit within IDEXX Laboratories, Editas Medicine, Arconic, Cardtronics, Cloudera, and BMC Stock — Research Highlights Growth, Revenue, and Consolidated Results

NEW YORK, Nov. 12, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of IDEXX Laboratories, Inc. (NASDAQ:IDXX), Editas Medicine, Inc. (NASDAQ:EDIT), Arconic Inc. (NYSE:ARNC), Cardtronics PLC (NASDAQ:CATM), Cloudera, Inc. (NYSE:CLDR), and BMC Stock Holdings, Inc. (NASDAQ:BMCH), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

IDXX DOWNLOAD: http://MarketSourceResearch.com/register/?so=IDXX
EDIT DOWNLOAD: http://MarketSourceResearch.com/register/?so=EDIT
ARNC DOWNLOAD: http://MarketSourceResearch.com/register/?so=ARNC
CATM DOWNLOAD: http://MarketSourceResearch.com/register/?so=CATM
CLDR DOWNLOAD: http://MarketSourceResearch.com/register/?so=CLDR
BMCH DOWNLOAD: http://MarketSourceResearch.com/register/?so=BMCH

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine IDEXX Laboratories, Inc. (NASDAQ:IDXX), Editas Medicine, Inc. (NASDAQ:EDIT), Arconic Inc. (NYSE:ARNC), Cardtronics PLC (NASDAQ:CATM), Cloudera, Inc. (NYSE:CLDR), and BMC Stock Holdings, Inc. (NASDAQ:BMCH) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed November 8th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

IDEXX LABORATORIES, INC. (IDXX) REPORT OVERVIEW

IDEXX Laboratories' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, IDEXX Laboratories reported revenue of $545.45MM vs $491.98MM (up 10.87%) and analysts estimated basic earnings per share $1.07 vs $0.81 (up 32.10%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, IDEXX Laboratories reported revenue of $1,969.06MM vs $1,775.42MM (up 10.91%) and analysts estimated basic earnings per share $3.00 vs $2.47 (up 21.46%). Analysts expect earnings to be released on February 7th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.77. The estimated EPS forecast for the next fiscal year is $4.68 and is expected to report on February 7th, 2019.

To read the full IDEXX Laboratories, Inc. (IDXX) report, download it here: http://MarketSourceResearch.com/register/?so=IDXX

-----------------------------------------

EDITAS MEDICINE, INC. (EDIT) REPORT OVERVIEW

Editas Medicine's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Editas Medicine reported revenue of $7.37MM vs $3.10MM (up 138.04%) and analysts estimated basic earnings per share -$0.82 vs -$0.65. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Editas Medicine reported revenue of $13.73MM vs $6.05MM (up 126.80%) and analysts estimated basic earnings per share -$2.98 vs -$3.02. Analysts expect earnings to be released on March 5th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was -$0.84. The estimated EPS forecast for the next fiscal year is -$3.36 and is expected to report on March 5th, 2019.

To read the full Editas Medicine, Inc. (EDIT) report, download it here: http://MarketSourceResearch.com/register/?so=EDIT

-----------------------------------------

ARCONIC INC. (ARNC) REPORT OVERVIEW

Arconic's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Arconic reported revenue of $3,524.00MM vs $3,236.00MM (up 8.90%) and analysts estimated basic earnings per share $0.33 vs $0.23 (up 43.48%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Arconic reported revenue of $12,960.00MM vs $12,394.00MM (up 4.57%) and analysts estimated basic earnings per share -$0.28 vs -$2.31. Analysts expect earnings to be released on February 4th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.31. The estimated EPS forecast for the next fiscal year is $1.60 and is expected to report on February 4th, 2019.

To read the full Arconic Inc. (ARNC) report, download it here: http://MarketSourceResearch.com/register/?so=ARNC

-----------------------------------------

CARDTRONICS PLC (CATM) REPORT OVERVIEW

Cardtronics' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Cardtronics reported revenue of $340.18MM vs $401.95MM (down 15.37%) and basic earnings per share $0.19 vs -$3.84. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Cardtronics reported revenue of $1,507.60MM vs $1,265.36MM (up 19.14%) and analysts estimated basic earnings per share -$3.19 vs $1.95. Analysts expect earnings to be released on February 19th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.67. The estimated EPS forecast for the next fiscal year is $1.85 and is expected to report on February 19th, 2019.

To read the full Cardtronics PLC (CATM) report, download it here: http://MarketSourceResearch.com/register/?so=CATM

-----------------------------------------

CLOUDERA, INC. (CLDR) REPORT OVERVIEW

Cloudera's Recent Financial Performance

For the three months ended July 31st, 2018 vs July 31st, 2017, Cloudera reported revenue of $110.34MM vs $89.83MM (up 22.83%) and analysts estimated basic earnings per share -$0.22 vs -$0.48. For the twelve months ended January 31st, 2018 vs January 31st, 2017, Cloudera reported revenue of $367.44MM vs $261.03MM (up 40.77%) and analysts estimated basic earnings per share -$3.38 vs -$5.15. Analysts expect earnings to be released on December 6th, 2018. The report will be for the fiscal period ending October 31st, 2018. The reported EPS for the same quarter last year was -$0.39. The estimated EPS forecast for the next fiscal year is -$1.09 and is expected to report on April 2nd, 2019.

To read the full Cloudera, Inc. (CLDR) report, download it here: http://MarketSourceResearch.com/register/?so=CLDR

-----------------------------------------

BMC STOCK HOLDINGS, INC. (BMCH) REPORT OVERVIEW

BMC Stock's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, BMC Stock reported revenue of $990.26MM vs $881.01MM (up 12.40%) and analysts estimated basic earnings per share $0.53 vs $0.28 (up 89.29%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, BMC Stock reported revenue of $3,365.97MM vs $3,093.74MM (up 8.80%) and analysts estimated basic earnings per share $0.86 vs $0.47 (up 82.98%). Analysts expect earnings to be released on February 26th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.23. The estimated EPS forecast for the next fiscal year is $1.68 and is expected to report on February 26th, 2019.

To read the full BMC Stock Holdings, Inc. (BMCH) report, download it here: http://MarketSourceResearch.com/register/?so=BMCH

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com

© 2018 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Powered by EIN News
Distribution channels:


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release